Article Text

PDF
Letters
Probiotics for preterm neonates: parents’ perspectives and present prevalence
  1. Rajesh Sesham1,
  2. Sam Oddie2,
  3. Nicholas D Embleton3,
  4. Paul Clarke1
  1. 1 Neonatal Unit, Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, UK
  2. 2 Neonatal Unit, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK
  3. 3 Newcastle Neonatal Service, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  1. Correspondence to Dr P Clarke, Consultant Neonatologist, Neonatal Intensive Care Unit, Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, NR4 7UY, UK; paul.clarke{at}nnuh.nhs.uk

Statistics from Altmetric.com

Meta-analyses indicate that giving probiotics to preterm neonates significantly decreases risk of necrotising enterocolitis (NEC) or death.13 Multiple randomised controlled trials including >5000 very low birthweight (VLBW) infants have not shown any adverse effects associated with probiotic use,3 and no disadvantages to growth or neurodevelopment are apparent.4 Routine probiotic supplementation has been offered in Bradford since September 2011 and in Norwich and Newcastle since January 2013 via Probiotics in Neonates Collaboration (PINC-UK). We treat all infants born <32 weeks’ gestation and all VLBW preterm infants using Infloran, a probiotic produced to assured drug quality standards using Good Manufacturing Practices (Desma Healthcare, Switzerland). This provides a daily dose of 1 billion each of live Lactobacillus acidophilus and Bifidobacterium bifidum at a cost of ∼£1 per day. Parents either receive a written …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.